{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:48:46Z","timestamp":1789674526472,"version":"4.0.1"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T00:00:00Z","timestamp":1375747200000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>JC virus (JCV) seropositivity is a risk factor for progressive multifocal leukoencephalopathy (PML) in patients on natalizumab. Accordingly, the JCV serological antibody test is of paramount importance in determining disease risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We tested the accuracy of the JCV serum antibody test by comparing the results of JCV serology to JCV viruria and viremia in 67 patients enrolled in a single\u2010center, retrospective cohort study. Bodily fluids (urine and blood) were assessed for JCV DNA by real time quantitative polymerase chain reaction 6 to 47 months (mean\u2009=\u200926.1 months) before JCV antibody testing. In 10 individuals, blood and urine samples were obtained on 2 separate occasions at 6\u2010month intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty (59.7%) of the 67 patients were JCV seropositive. Of 27 JCV seronegative patients, 10 (37%) had JCV viruria. Urine JCV DNA copy numbers were significantly higher in the seropositive group (mean log copy number\u2009=\u20095.93, range\u2009=\u20091.85\u20139.21) than the seronegative group (mean log copy number\u2009=\u20092.41, range\u2009=\u20091.85\u20135.43;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0026). Considering all body fluid test results, 50 (74.6%) of the 67 patients were previously infected with JCV.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>The false\u2010negative rate of the JCV serology in this study was 37%; therefore, JCV serostatus does not appear to identify all patients infected with JCV. Thus, a negative JCV antibody result should not be conflated with absence of JCV infection. This discordance may be important in understanding JCV biology, risk for PML, and PML pathogenesis. Ann Neurol 2013;74:84\u201390<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ana.23893","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T16:52:23Z","timestamp":1364057543000},"page":"84-90","source":"Crossref","is-referenced-by-count":76,"title":["JC virus antibody status underestimates infection rates"],"prefix":"10.1002","volume":"74","author":[{"given":"Joseph R.","family":"Berger","sequence":"first","affiliation":[{"name":"Department of Neurology College of Medicine, and Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney A.","family":"Houff","sequence":"additional","affiliation":[{"name":"Department of Neurology College of Medicine, and Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gurwell","sequence":"additional","affiliation":[{"name":"Department of Neurology College of Medicine, and Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubia","family":"Vega","sequence":"additional","affiliation":[{"name":"Department of Neurology College of Medicine, and Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Oral Health Practice College of Dentistry, University of Kentucky Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Danaher","sequence":"additional","affiliation":[{"name":"Department of Oral Health Practice College of Dentistry, University of Kentucky Lexington KY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"key":"e_1_2_5_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"e_1_2_5_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051847"},{"key":"e_1_2_5_3_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"e_1_2_5_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054693"},{"key":"e_1_2_5_3_6_1","unstructured":"TYSABRI Safety Update.2012. Available at:https:\/\/medinfo.biogenidec.com\/medinfo\/secure\/pmlresource.do?resource=TYSABRIPMLSafetyUpdateAccessed August 20 2012."},{"key":"e_1_2_5_3_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.66.1.238-245.2000"},{"key":"e_1_2_5_3_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/504947"},{"key":"e_1_2_5_3_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.2.253"},{"key":"e_1_2_5_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20005"},{"key":"e_1_2_5_3_11_1","first-page":"495","article-title":"The pathogenesis of progressive multifocal leukoencephalopathy","volume":"12","author":"Berger JR","year":"2012","journal-title":"Discov Med"},{"key":"e_1_2_5_3_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/127.4.467"},{"key":"e_1_2_5_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1982.tb00254.x"},{"key":"e_1_2_5_3_14_1","first-page":"99","volume-title":"Polyomaviruses and human neurological disease","author":"Walker D","year":"1983"},{"key":"e_1_2_5_3_15_1","first-page":"161","volume-title":"Comprehensive virology","author":"Walker D","year":"1983"},{"key":"e_1_2_5_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10450"},{"key":"e_1_2_5_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21710"},{"key":"e_1_2_5_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-012-0107-0"},{"key":"e_1_2_5_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22128"},{"key":"e_1_2_5_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.13.1001"},{"key":"e_1_2_5_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22606"},{"key":"e_1_2_5_3_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.27.6.1174-1179.1989"},{"key":"e_1_2_5_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2004.06.021"},{"key":"e_1_2_5_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70006-5"},{"key":"e_1_2_5_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0928-0197(95)00012-W"},{"key":"e_1_2_5_3_26_1","first-page":"107","article-title":"Virologic and serologic studies of progressive multifocal leukoencephalopathy","volume":"105","author":"Padgett BL","year":"1983","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_5_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/13550280152537166"},{"key":"e_1_2_5_3_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2000.00009.x"},{"key":"e_1_2_5_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir507"},{"key":"e_1_2_5_3_30_1","unstructured":"LeeP PlavinaT CastroA et al.An enhanced ELISA for detection of anti\u2010JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. Paper presented at: 22nd Annual Meeting of the European Neurological Society; June 9\u201312 2012; Prague Czech Republic (P467)."},{"key":"e_1_2_5_3_31_1","unstructured":"EtxeberriaA OutteryckO OngagnaJC et al.Annual rate of JCV seroconversion in a French cohort of MS patients under natalizumab. In: European Committee for Treatment and Research in Multiple Sclerosis Congress; October 10\u201313 2012; Lyon France (P996)."},{"key":"e_1_2_5_3_32_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182768983"},{"key":"e_1_2_5_3_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182583022"},{"key":"e_1_2_5_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22137"},{"key":"e_1_2_5_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22304"},{"key":"e_1_2_5_3_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"e_1_2_5_3_37_1","first-page":"495","article-title":"The pathogenesis of progressive multifocal leukoencephalopathy","volume":"12","author":"Berger JR","year":"2011","journal-title":"Discov Med"},{"key":"e_1_2_5_3_38_1","first-page":"110","article-title":"Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV\u2010DNA, HBeAg\/anti\u2010HBe, and liver function tests","volume":"33","author":"Hasan KN","year":"2002","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_5_3_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.006"},{"key":"e_1_2_5_3_40_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0614"},{"key":"e_1_2_5_3_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.145698"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.23893","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.23893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:00:33Z","timestamp":1696575633000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.23893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/ana.23893"],"URL":"https:\/\/doi.org\/10.1002\/ana.23893","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}